This study has provided lncRNA NEAT1, miR-23a and MDM2 as candidate diagnostic biomarkers or potential therapeutic targets for RA and will broaden our understanding of the pathogenesis underlying RA. Here, MDM2 is linked to rheumatoid arthritis.